Sima Lev
Affiliations: | Molecular Cell Biology | Weizmann Institute of Science, Rehovot, Israel |
Area:
Molecular Biology, Microbiology BiologyGoogle:
"Sima Lev"Parents
Sign in to add mentor| Yosef Yarden | grad student | Weizmann Institute | |
| Joseph Schlessinger | post-doc | Yale School of Medicine (Neurotree) |
Children
Sign in to add trainee| Amir Kedan | grad student | Weizmann Institute | |
| Omer Keinan | grad student | Weizmann Institute | |
| SoHui Kim | grad student | Weizmann Institute | |
| Vladimir Litvak | grad student | Weizmann Institute | |
| Michael Selitrennik | grad student | Weizmann Institute | |
| Nili Dahan | grad student | 2008 | Weizmann Institute |
| Orly Laufman | grad student | 2010 | Weizmann Institute |
| Anna-K. Mueller | post-doc | Weizmann Institute | |
| Diego Peretti | post-doc | Weizmann Institute | |
| Nandini Verma | post-doc | Weizmann Institute | |
| Effrosini Panayotopoulou | post-doc | 2014- | Weizmann Institute |
| Ulrike A Koehler | post-doc | 2017- | Weizmann Institute |
BETA: Related publications
See more...
Publications
|
You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect. |
| Vinik Y, Maimon A, Dubey V, et al. (2024) Programming a Ferroptosis-to-Apoptosis Transition Landscape Revealed Ferroptosis Biomarkers and Repressors for Cancer Therapy. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2307263 |
| Gil-Henn H, Girault JA, Lev S. (2023) PYK2, a hub of signaling networks in breast cancer progression. Trends in Cell Biology |
| Nataraj NB, Noronha A, Lee JS, et al. (2022) Nucleoporin-93 reveals a common feature of aggressive breast cancers: robust nucleocytoplasmic transport of transcription factors. Cell Reports. 38: 110418 |
| Müller AK, Köhler UA, Trzebanski S, et al. (2022) Mouse Modeling Dissecting Macrophage-Breast Cancer Communication Uncovered Roles of PYK2 in Macrophage Recruitment and Breast Tumorigenesis. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). e2105696 |
| Castellanet O, Ahmad F, Vinik Y, et al. (2021) BCL-XL blockage in TNBC models confers vulnerability to inhibition of specific cell cycle regulators. Theranostics. 11: 9180-9197 |
| Khera L, Lev S. (2021) Accelerating AXL targeting for TNBC therapy. The International Journal of Biochemistry & Cell Biology. 106057 |
| Khera L, Vinik Y, Maina F, et al. (2021) The AXL-PYK2-PKCα axis as a nexus of stemness circuits in TNBC. Life Science Alliance. 4 |
| Lamballe F, Ahmad F, Vinik Y, et al. (2021) Modeling Heterogeneity of Triple-Negative Breast Cancer Uncovers a Novel Combinatorial Treatment Overcoming Primary Drug Resistance. Advanced Science (Weinheim, Baden-Wurttemberg, Germany). 8: 2003049 |
| Vinik Y, Ortega FG, Mills GB, et al. (2020) Proteomic analysis of circulating extracellular vesicles identifies potential markers of breast cancer progression, recurrence, and response. Science Advances. 6 |
| Verma N, Vinik Y, Saroha A, et al. (2020) Synthetic lethal combination targeting BET uncovered intrinsic susceptibility of TNBC to ferroptosis. Science Advances. 6 |